BioCentury
ARTICLE | Clinical News

Inhaled dronabinol: Phase I

August 11, 2003 7:00 AM UTC

Solvay subsidiary Unimed Pharmaceuticals Inc. began a Phase I trial of inhaled dronabinol. Dronabinol is the active ingredient of Unimed's Marinol product, which is approved in the U.S. to treat ano...